Goldman Sachs Group Inc Pro Phase Labs, Inc. Transaction History

Goldman Sachs Group Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$4.47 - $6.47 $61,288 - $88,710	-13,711 Reduced 36.57%	23,786 $153,000
Q4 2023 Feb 13, 2024	SELL	$4.35 - $5.1 $220,397 - $258,396	-50,666 Reduced 57.47%	37,497 $169,000
Q3 2023 May 14, 2024	BUY	$4.23 - $7.53 $214,317 - $381,514	50,666 Added 135.12%	88,163 $385,000
Q3 2023 Nov 14, 2023	BUY	$4.23 - $7.53 $372,929 - $663,867	88,163 New	88,163 $385,000
Q4 2022 May 14, 2024	BUY	$8.78 - $12.47 $4,609 - $6,546	525 Added 4.07%	13,430 $129,000
Q4 2022 Feb 13, 2023	BUY	$8.78 - $12.47 $117,915 - $167,472	13,430 New	13,430 $129,000
Q2 2022 May 14, 2024	SELL	$6.52 - $13.24 $160,339 - $325,598	-24,592 Reduced 65.58%	12,905 $164,000
Q2 2022 Aug 15, 2022	BUY	$6.52 - $13.24 $84,140 - $170,862	12,905 New	12,905 $164,000

1.91M

Ticker PRPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 16,024,400
Market Cap $9.77M
Description
ProPhase Labs, Inc. engages in the research, development, manufacture, distribution, marketing, and sale of over the counter (OTC) consumer healthcare products and dietary supplements in the United States. The company operates in two segments, Diagnostic Services and Consumer Products. It offers a range of OTC dietary supplements, including Lege...

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

Stay updated on Goldman Sachs Group Inc with notifications on news.